Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2003-02-06
2011-10-25
Sang, Hong (Department: 1643)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Reexamination Certificate
active
08043602
ABSTRACT:
A method of differentiating tumors from healthy cells in tissue is disclosed. The method includes the steps of providing a marker-folate conjugate, placing the marker-folate conjugate in contact with the tissue and viewing the tissue.
REFERENCES:
patent: 2816110 (1957-12-01), Sletzinger et al.
patent: 4577636 (1986-03-01), Spears
patent: 4641650 (1987-02-01), Mok
patent: 4713249 (1987-12-01), Schroder
patent: 4718417 (1988-01-01), Kittrell et al.
patent: 4785806 (1988-11-01), Deckelbaum
patent: 4817601 (1989-04-01), Roth et al.
patent: 4850351 (1989-07-01), Herman et al.
patent: 4917084 (1990-04-01), Sinofsky
patent: 4950266 (1990-08-01), Sinofsky
patent: 5094848 (1992-03-01), Brixner
patent: 5108921 (1992-04-01), Low et al.
patent: 5140104 (1992-08-01), Coughlin et al.
patent: 5192525 (1993-03-01), Yang et al.
patent: 5217456 (1993-06-01), Narciso
patent: 5266333 (1993-11-01), Cady et al.
patent: 5275594 (1994-01-01), Baker et al.
patent: 5336506 (1994-08-01), Josephson et al.
patent: 5373093 (1994-12-01), Vallarino et al.
patent: 5399338 (1995-03-01), Born et al.
patent: 5416016 (1995-05-01), Low et al.
patent: 5417982 (1995-05-01), Modi
patent: 5547668 (1996-08-01), Kranz et al.
patent: 5552545 (1996-09-01), Pearce et al.
patent: 5562100 (1996-10-01), Kittrell et al.
patent: 5576305 (1996-11-01), Ratcliffe
patent: 5688488 (1997-11-01), Low et al.
patent: 5753631 (1998-05-01), Paulson et al.
patent: 5759546 (1998-06-01), Weinberg et al.
patent: 5820847 (1998-10-01), Low et al.
patent: 6093382 (2000-07-01), Wedeking et al.
patent: 6167297 (2000-12-01), Benaron
patent: 6204371 (2001-03-01), Levinson
patent: 6217847 (2001-04-01), Contag et al.
patent: 6246901 (2001-06-01), Benaron
patent: 6270766 (2001-08-01), Feldman et al.
patent: 6335434 (2002-01-01), Guzaev et al.
patent: 6365362 (2002-04-01), Terstappen et al.
patent: 6387350 (2002-05-01), Goldenberg
patent: 6507747 (2003-01-01), Gowda et al.
patent: 6780984 (2004-08-01), Wang et al.
patent: 6782289 (2004-08-01), Strauss
patent: 6960449 (2005-11-01), Wang et al.
patent: 7033594 (2006-04-01), Low et al.
patent: 7128893 (2006-10-01), Leamon et al.
patent: 7223380 (2007-05-01), Yang et al.
patent: 7601332 (2009-10-01), Vlahov
patent: 2001/0031252 (2001-10-01), Low et al.
patent: 2002/0127181 (2002-09-01), Edwards et al.
patent: 2002/0192157 (2002-12-01), Low
patent: 2003/0198643 (2003-10-01), Lu
patent: 2003/0219375 (2003-11-01), Piwnica-Worms
patent: 2004/0033195 (2004-02-01), Leamon et al.
patent: 2004/0057900 (2004-03-01), Edwards et al.
patent: 2004/0136910 (2004-07-01), Jallad et al.
patent: 2004/0184990 (2004-09-01), Larsen et al.
patent: 2005/0002942 (2005-01-01), Vlahov et al.
patent: 2005/0026866 (2005-02-01), Pawelek
patent: 2005/0244336 (2005-11-01), Low
patent: 2006/0002891 (2006-01-01), Pouletty
patent: 2006/0067946 (2006-03-01), Low et al.
patent: 2006/0134002 (2006-06-01), Lin
patent: 2006/0204565 (2006-09-01), Low et al.
patent: 2007/0009434 (2007-01-01), Low et al.
patent: 2007/0031334 (2007-02-01), Leamon et al.
patent: 2007/0231266 (2007-10-01), Low
patent: 2007/0276231 (2007-11-01), Low et al.
patent: 2008/0119475 (2008-05-01), Low et al.
patent: 2008/0138396 (2008-06-01), Low et al.
patent: 2008/0254499 (2008-10-01), Low
patent: 2009/0012009 (2009-01-01), Low et al.
patent: 2010/0055735 (2010-03-01), Low
patent: 21 23338 (1996-11-01), None
patent: 90/12096 (1990-10-01), None
patent: 91/19501 (1991-12-01), None
patent: 91/19502 (1991-12-01), None
patent: WO 96/22521 (1996-07-01), None
patent: 96/36367 (1996-11-01), None
patent: 97/37690 (1997-10-01), None
patent: 01/19320 (2001-03-01), None
patent: 01/39806 (2001-06-01), None
patent: WO 01/47552 (2001-07-01), None
patent: 01/74382 (2001-10-01), None
patent: 02/087424 (2002-11-01), None
patent: 2004/110250 (2004-12-01), None
patent: 2005/087275 (2005-09-01), None
patent: 2006/012527 (2006-02-01), None
patent: WO 2006/034046 (2006-03-01), None
patent: WO 2006/065943 (2006-06-01), None
patent: 2006/071754 (2006-07-01), None
patent: 2006/101845 (2006-09-01), None
patent: 2007/006041 (2007-01-01), None
patent: WO 2008/148001 (2008-04-01), None
patent: 2008/098112 (2008-08-01), None
patent: 2009/002993 (2008-12-01), None
patent: WO 2009/026177 (2009-02-01), None
Leamon et al (DDT vol. 6 No. 1 Jan. 2001:44-51).
Mahmood et al (Radiology, 1999. 213:866-870).
NCBI, MeSH definition for “Indocarbocyanine Green”, 2 pages, retrieved from NCBI site on Sep. 3, 2008.
Greenman, Y., et al., “Heterogeneous Expression of Two Somatostatin Receptor Subtypes in Pituitary Tumors,” Journal of Clinical Endocrinology and Metabolism, vol. 78. No. 2. pp. 398-403 (1994).
U.S. Appl. No. 61/235,220, filed Aug. 19, 2009, Low et al.
U.S. Appl. No. 61/157,847, filed Mar. 5, 2009, Low et al.
“Osteomyelitis”, XP-002569963, URL:http://emedicine.medscape.com/article/785020-overview>, retrieved Feb. 22, 2010.
Holladay et al., “Riboflavin-mediated delivery of a macromolecule into cultured human cells,”Biochim Biophys Acta1426(1): 195-204 (1999).
Kennedy et al., “Optical imaging of metastatic tumors using a folate-targeted fluorescent probe,”J. of Biomedical Optics, vol. 8, No. 4, pp. 636-641, Oct. 2003.
Low PS, Leamon CP, Reddy JA, Green MA, Mathias C, Turk MJ, Waters DJ, Lu J, Lee RJ, Kennedy MD, “Folate-mediated delivery of therapeutic and imaging agents to cancer tissue,” Gene, Drug Therapy, and Molecular Biology (Abstract), 2000.
Low, P.S., Leamon, C.P., Reddy, J.A., Green, M.A., Mathias, C., Turk, M.J., Waters, D.J., Lu, J., Lee, R.J. and Kennedy, M., “Folate-Mediated Delivery of Therapeutic and Imaging Agents to Cancer Tissues In Vivo,”International Symposium on Tumor Targeted Delivery Systems, Bethesda, Maryland. British Journal of Pharmacology, vol. 134 (Abstract), 2001.
Barnes, H. H., et al., “Purification of Catechol Siderophores by Boronate Affinity Chromatography: Identification of Chrysobactin FromErwinia carotovorasubsp.carotovora”, 1999,BioMetals, vol. 12, pp. 83-87.
Collins, Peter, et al., “Monosaccharides, Their Chemistry and Their Roles in Natural Products”, 1995Wiley Publishers, Book Reference, We will provide the book if requested.
Georgakoudi, Irene, et al., “In Vivo Flow Cytometry: A New Method for Enumerating Circulating Cancer Cells”, Aug. 1, 2004,Cancer Research, No. 64, pp. 5044-5047.
Hanessian, Stephen, “Preparative Carbohydrate Chemistry”, 1997Marcel Dekker, Inc., Book Reference, We will provide the book if requested.
Idanpaan-Heikkila, Ilona, et al., “Oligosaccharides Interfere With the Establishment and Progression of Experimental Pneumococcal Pneumonia”, 1997,The Journal of Infectious Diseases, No. 176, pp. 704-712.
Iijima, Masatomi, et al., “IC202A, A New Siderophore With Immunosuppressive Activity Produced byStreptoalloteichussp. 1454-19. I. Taxonomy, fermentation, isolation and biological activity.”, Jan. 1999,The Journal of Antibiotics(Toyko), vol. 52, No. 1, pp. 20-24.
Lingwood, Clifford A., “Oligosaccharide Receptors for Bacteria: A View to a Kill”, 1998,Curr Opin Chem Biol., pp. 695-700.
Michelson, Alan D., et al., “Evaluation of Platelet Function by Flow Cytometry”, 2000, Methods, vol. 21, pp. 259-270.
Novak, J., et al., “In Vivo Flow Cytometer for Real-Time Detection and Quantification of Circulating Cells”, Jan. 1, 2004Optics Letters, vol. 29, No. 1, pp. 77-79.
Ratledge, Colin, et al., “The Occurrence of Carboxymycobactin, the Siderophore of Pathogenic Mycobacteria, as a Second Extracellular Siderophore inMycobacterium smegmatis”, 1996Microbiology, vol. 142, pp. 2207-2212.
Scharfman, Andree, et al., “Pseudomonas aeruginosaBinds to Neoglycoconjugates Bearing Mucin Carbohydrate Determinants and Predominantly to sialyl-Lewis x Conjugates”, 1999,Glycobiology, vol. 9, No. 8, pp. 757-764.
Albrecht-Gary et al., “Bacterial Iron Transport: Coordination Properties of Pyoverdin PaA, a Peptidic Siderophore of
Ben-Amotz Dor
Jallad Karim N.
Kennedy Michael D.
Low Philip S.
Barnes & Thornburg LLP
Endocyte, Inc.
Sang Hong
LandOfFree
Folate targeted enhanced tumor and folate receptor positive... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Folate targeted enhanced tumor and folate receptor positive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Folate targeted enhanced tumor and folate receptor positive... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4299327